US 12,168,650 B2
Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile
Bakary-Barry Toure, Weston, MA (US); and Magnus Ronn, Melrose, MA (US)
Assigned to NIDO BIOSCIENCES, INC., Cambridge, MA (US)
Filed by NIDO BIOSCIENCES, INC., Cambridge, MA (US)
Filed on Jan. 13, 2023, as Appl. No. 18/154,205.
Claims priority of provisional application 63/299,678, filed on Jan. 14, 2022.
Prior Publication US 2023/0257361 A1, Aug. 17, 2023
Int. Cl. C07D 401/04 (2006.01); A61P 35/00 (2006.01)
CPC C07D 401/04 (2013.01) [A61P 35/00 (2018.01); C07B 2200/13 (2013.01)] 13 Claims
 
1. A crystalline form of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile.